About 200 reports

EXECUTIVE SUMMARY ##.

  • Obesity
  • Pathology
  • Surgical Equipment
  • World
  • Market Shares
  • Anti-obesity drugs Industry
  • Anti-obesity Drugs Production and Demand

ANTI-OBESITY DRUGS PRODUCER DIRECTORY This is Herbalife' s one and only manufacturing base apart from the one in America.

  • Obesity
  • China
  • Demand
  • Abbott Laboratories, Inc.
  • Shanghai Jahwa United Co., Ltd.
  • Anti-obesity drugs Industry
  • Anti-Obesity Drugs Companies in China

ANTI-OBESITY DRUGS PRODUCER DIRECTORY This is Herbalife' s one and only manufacturing base apart from the one in America.

  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.
  • Other Anti-obesity Drugs
  • Anti-obesity Drugs Imports

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for anti-obesity drugs in China is growing rapidly.

  • Obesity
  • Pathology
  • China
  • Demand
  • Abbott Laboratories, Inc.

Factors such as the increase in childhood obesity incidence and the use of implantable neuroregulatory devices for treating obesity, will provide considerable growth opportunities to anti-obesity drugs manufactures.

  • Obesity
  • Pathology
  • World

GLP-## receptor agonists ##. ##. ##. ##.

  • Obesity
  • Pathology
  • World
  • Demand
  • Forecast

Global Anti-Obesity Drugs Market Forecast 2018-2028 ##.

  • Obesity
  • Pathology
  • World
  • Market Shares

Pricing Details List of Figures FIGURE ##.

  • Obesity
  • United States
  • World
  • Market Size

Pricing Details List of Figures FIGURE ##.

  • Obesity
  • Prescription Drug
  • United States
  • World
  • Market Size
  • 2 Obesity: Executive Summary
  • 4.3 SUSTAINED INNOVATION IN OBESITY

Table ##: Nutritional status Obesity can be classified based on different BMI.

  • Obesity
  • Pathology
  • World
  • Obesity 2021
  • Obesity is here to stay

While some ##% of children and adolescents aged ##-## were obese in 1975, this had risen to ##% of girls and ##% of boys in 2016.

  • Obesity
  • United Kingdom
  • United States
  • World
  • Demand

The approved drugs in the obesity space target gastric lipase, dopamine, norepinephrine (noradrenaline), dopamine reuptake, norepinephrine (noradrenaline) reuptake/ transporter, opioid receptors, GABA-A receptor, serotonin ##-HT##C receptor, and glucagon-like peptide-## (GLP-

  • Obesity
  • Pathology
  • European Union
  • Promising Drugs in Development for Obesity
  • Obesity - Key Facts

Report Code: GDHC##CL Published: October 2018 Obesity: Competitive Landscape to 2026 Healthcare TABLE OF CONTENTS ##.

  • Obesity
  • United States
  • Market Competition
  • Eisai Co., Ltd.
  • Novo Nordisk Group

##.

  • Obesity
  • Pathology
  • World
  • Market Size

Pricing Details List of Figures FIGURE ##.

  • Obesity
  • Prescription Drug
  • United States
  • Market Size

Anti-Obesity Prescription Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 ##.

  • Obesity
  • World
  • Demand
  • Market Shares
  • Market Size
  • Obesity
  • Obesity Rising

In 2017, hard discounter Dia (Argentina) launched ##% juice in one flavour and pack size.

  • Obesity
  • Pathology
  • Chile
  • Latin America
  • Demand
  • Japan Obesity Prevalence Rate, 2016
  • Africa Obesity Prevalence Rate, 2016

THE DETAILS ##.

  • Obesity
  • World
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • LifeScan, Inc.

##.

  • Obesity
  • Pathology
  • World
  • Market Size
  • Increasing Prevalence of Obesity
  • Government Initiatives for Childhood obesity

Currently, more than one in two adults, and nearly one in six children are obese.

  • Obesity
  • Forecast
  • Hologic, Inc.
  • Omron Corporation
  • Tanita Corporation
  • USA ANTI-ASTHMATICS AND COPD DRUGS MARKET OVERVIEW
  • UK ANTI-ASTHMATICS AND COPD DRUGS MARKET OVERVIEW

AS OF 2015, ONE IN EVERY FOUR PEOPLE IN THE UK WERE OBESE.

  • Obesity
  • World
  • Forecast
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • OBESITY
  • OBESITY

SUPPLIER POWER - LOW ##.

  • Obesity
  • World
  • OptiBiotix Health plc
  • PureTech LLC
  • Ritter Pharmaceuticals, Inc.

Obesity Surgery Devices Market by Procedure, by Type, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023 Chapter ##.

  • Obesity
  • APAC
  • World
  • Forecast
  • Market Size

North America alone is expected to account for ##/ ##rd of the global obesity management market North America is forecast to account for more than ##/ ##rd revenue share of the global obesity management market by 2017 and it should gain a substantial ## BPS b

  • Obesity
  • Pathology
  • World
  • Forecast
  • Global Obesity Prevalence,1990- 2014 (% of Adults Aged 18+ Years)
  • Oceania Obesity Prevalence, 1990-2014 (% of Adults Aged 18+ Years)

Table ##.

  • Obesity
  • World
  • ConAgra Foods, Inc.
  • GlaxoSmithKline plc
  • Unilever PLC

Global Obesity Epidemiology and Patient Flow Analysis - 2017 ##.

  • Obesity
  • Pathology
  • United States
  • World
  • Forecast
  • MM, Sources Used for Obesity Prevalence
  • shows the sources used to calculate obesity prevalence in the 7MM.

S##. doi: ##. ##/ S##-##(##)##-##.

  • Epidemiology
  • Obesity
  • Pathology
  • United States
  • Forecast
  • ADULTS WITH OBESITY WORLDWIDE
  • IMPACT OF RISING NUMBER OF OBESITY CASES

OBESITY IS ONE OF THE MAJOR RISK FACTORS FOR INFERTILITY.

  • Hospital
  • Obesity
  • World
  • Market Size
  • Merck & Co., Inc.

Biomarker-based research may also open novel paradigms for drug discovery and development obesity and diabetes disorders.

  • Biomarker
  • Genomics Proteomics And Enabling Technology
  • Obesity
  • World
  • Forecast
  • A) Obesity prevalence
  • Diabetes an d obesity

Obesity Research; ##(##): ##-## Sands AT, et al. (2015).

  • Obesity
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.